Description
The abstract describes ‘surprising diversity’ of TARDBP isoforms with unique functions but doesn’t explain how these variants mechanistically drive disease pathogenesis. Understanding this link is critical for developing splice-targeted therapeutics.
Gap type: unexplained_observation Source paper: Splicing the narrative: alternative TARDBP splicing and its relation to neurodegeneration in ALS and FTD. (2026, The Journal of clinical investigation, PMID:41837283)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:27.378062+00:00”, “resolution_summary”: “Resolved by hypothesis h-var-a0933e666d: Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-var-a0933e666d”, “title”: “Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD”, “score”: 0.413, “reason”: “11 token overlaps; entity overlap: als, ftd, tardbp”, “analysis_id”: “SDA-2026-04-01-gap-20260401-225149”, “target_gene”: “AIM2, CASP1, IL1B, PYCARD, TARDBP”, “target_pathway”: “Microglial AIM2 inflammasome activation via phagocytosed neuron-derived mtDNA in TDP-43 proteinopathy”, “disease”: “neurodegeneration”, “composite_score”: 0.8240000000000001, “confidence_score”: 0.76, “status”: “proposed”, “pubmed_evidence_ids”: [“27519954”, “28506519”, “29263430”, “29643512”, “30610225”]}, {“id”: “h-72c719461c”, “title”: “C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD”, “score”: 0.358, “reason”: “5 token overlaps; entity overlap: als, ftd”, “analysis_id”: “test-hypothesis-fixtures-v1”, “target_gene”: “C9orf72”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.88, “status”: “proposed”, “pubmed_evidence_ids”: [“21944792”, “28960178”, “29460270”, “39605053”, “40520109”]}, {“id”: “ec8b839c-6440-45dc-aff6-5edea1fd2d6d”, “title”: “STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Function Marker of TDP-43 Nuclear Depletion in ALS Motor Neurons”, “score”: 0.328, “reason”: “4 token overlaps; entity overlap: als, tardbp”, “analysis_id”: “0ed3c364-07fd-4620-8e90-8bd33c14e370”, “target_gene”: “TARDBP”, “target_pathway”: “TDP-43 splicing regulation / axon maintenance”, “disease”: “ALS”, “composite_score”: 0.720856, “confidence_score”: 0.6, “status”: “open”, “pubmed_evidence_ids”: [“30643292”, “34879411”, “34930382”, “36927019”, “38967083”]}, {“id”: “h-alsmnd-c5d2e9c2edeb”, “title”: “SFPQ Paralog Displacement Triggers Cryptic Polyadenylation and Global RNA Stability Loss in ALS Motor Neurons”, “score”: 0.327, “reason”: “6 token overlaps; entity overlap: als, tardbp”, “analysis_id”: null, “target_gene”: “SFPQ,NONO,PSP1,TARDBP,poly(A) machinery,CPSF,PABPN1”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.864139, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“36414621”, “40369342”, “41120750”, “41836882”]}, {“id”: “h-530326b97069”, “title”: “SASP-Secreted MMP-9 from Senescent Microglia Generates Pathological TDP-43 C-Terminal Fragments That Propagate ALS Pathology”, “score”: 0.297, “reason”: “4 token overlaps; entity overlap: als, tardbp”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “MMP9 → TARDBP (C-terminal fragments) → cytoplasmic aggregation seeding”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.713424, “confidence_score”: 0.3, “status”: “proposed”, “pubmed_evidence_ids”: [“21209826”, “30458231”, “33300249”, “39067491”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “title”: “The authors evaluate several ALS-associated mutations in OPTN’s leucine-zipper domain but don’t fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.\n\nGap type: unexplained_observation\nSource paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)”, “score”: 0.657, “reason”: “15 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “title”: “The abstract reveals FUS has a chaperone-like function regulating TAZ condensate dynamics, but doesn’t address how FUS mutations in ALS/FTD might disrupt this function. This gap is critical since FUS mutations cause neurodegeneration, yet this newly discovered role in transcriptional regulation remains unexplored in disease context.\n\nGap type: open_question\nSource paper: A chaperone-like function of FUS ensures TAZ condensate dynamics and transcriptional activation. (None, None, PMID:38172614)”, “score”: 0.637, “reason”: “10 token overlaps; entity overlap: als, ftd, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-041423-3a6aa4ab_task_9aae8fc5”, “title”: “The study shows TRIM21 and autophagy receptors can eliminate both physiological and pathological SGs, yet persistent stress granules are hallmarks of ALS/FTD. The mechanisms by which disease-associated SGs evade this clearance system remain unclear but are critical for therapeutic targeting.\n\nGap type: open_question\nSource paper: Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules. (2023, Autophagy, PMID:36692217)”, “score”: 0.563, “reason”: “8 token overlaps; entity overlap: als, ftd, pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041423-3a6aa4ab”, “quality_score”: 0.746, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.547, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.526, “reason”: “11 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}